Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Cord blood bank Stories

2012-11-20 08:27:13

TUCSON, Ariz., Nov. 20, 2012 /PRNewswire/ -- Dr. David Harris, Professor of Immunology at the University of Arizona and a scientific pioneer in the field of stem cell banking, was the recipient of the Arizona BioIndustry Association(TM) (AZBIO) 2012 award for "20 Years of Discovery and Innovation". The annual AZBIO Awards is Arizona's premier bioscience event and was held at the Phoenix Convention Center. Dr. Harris is a graduate of Wake Forest University, the leading center for...

2012-11-19 04:21:39

EYSINS, Switzerland, November 19, 2012 /PRNewswire/ -- Biosafe Group SA, announced today that it has obtained Chinese SFDA registration for its Sepax(R) device, completing its worldwide registration program. Sepax is now available for immediate sale in China through Biosafe's recently established local subsidiary in Shanghai and is the first fully-automated cell separation system approved for use in the Chinese stem cell processing market. (Logo:...

2012-11-15 20:21:43

COVINA, Calif., Nov. 15, 2012 /PRNewswire/ -- StemCyte, Inc. proudly announces an agreement with the UC Davis Umbilical Cord Blood Collection (UCB) Program in Sacramento to advance the collection, processing and registration of high quality and diverse cord blood cells from California mothers for public banking. The cord blood will be used in treating patients facing life-threatening illnesses. The agreement is the first of its kind under California's unique statewide program. Legislation...

2012-11-13 12:29:32

OLDSMAR, Fla., Nov. 13, 2012 /PRNewswire/ -- Cryo-Cell International (OTC:QB Markets Group Symbol: CCEL) announced the appointment of Wayne Green, Ph.D., as director of flow cytometry. Dr. Green is responsible for overseeing the highly specialized method for analyzing and sorting blood cells in Cryo-Cell's state-of-the art laboratory. Flow cytometry studies enable the lab to separate stem cells from other blood cells in umbilical cord and menstrual specimens. (Photo:...

2012-11-12 08:26:27

HONG KONG, Nov. 12, 2012 /PRNewswire-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced its plan to release financial results for the second quarter and first half of fiscal year 2013 on Monday, November 19, 2012, after market close in the US. The Company will host a conference call at 8:00 a.m. ET on Tuesday, November 20, 2012 to discuss its financial performance and give a brief overview of the Company's recent developments, followed by...

2012-11-12 08:26:25

HONG KONG, Nov. 12, 2012 /PRNewswire-FirstCall/ -- China Cord Blood Corporation (NYSE:CO) ("CCBC" or the "Company"), the first and largest cord blood banking operator in China, today announced the successful completion of the transaction with Cordlife Group Limited (CLGL.SP) ("Cordlife"), a cord blood and tissue banking service provider listed on the Singapore Exchange Securities Trading Limited ("SGX-ST"). The transaction was first announced on August 15, 2012. As a result of the...

2012-10-29 07:24:42

BOTHELL, Wash., Oct. 29, 2012 /PRNewswire/ -- BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, today announced the Company's novel biopreservation technology is being used in more than 50 clinical trial-stage cellular therapies, making it the leading choice in the emerging, high growth field of regenerative...

2012-10-25 11:25:49

COVINA, Calif., Oct. 25, 2012 /PRNewswire/ -- StemCyte, Inc. is proud to announce that StemCyte Taiwan has met the eligibility requirements for accreditation by the Foundation for the Accreditation of Cellular Therapy (FACT), an organization helping to assure the highest standards in cellular therapy practices. StemCyte Taiwan's accreditation achievement matches its continued FACT accreditation at its Covina, California North American lab. The dual lab accreditation is further evidence of...

2012-10-22 15:25:47

HONG KONG, Oct. 22, 2012 /PRNewswire-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), the first and largest cord blood banking operator in China, today announced that the Company will hold its annual general meeting of shareholders at its Hong Kong office at 48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong, at 9:00 p.m. Hong Kong Time on December 19, 2012 (8:00 a.m. U.S. Eastern Time on December 19, 2012). Shareholders of record as of...

2012-10-22 07:28:44

HONG KONG, Oct. 22, 2012 /PRNewswire-FirstCall/ -- China Cord Blood Corporation (NYSE:CO) ("CCBC" or the "Company"), the first and largest cord blood banking operator in China, today announced that the Company repurchased an aggregate of 6,041,980 ordinary shares for a total consideration of approximately $16.4 million since April 1, 2012. The total number of shares issued and outstanding as of the date hereof is 73,140,147, with 6,041,980 shares being held as treasury shares. On...